Skip to main content
. Author manuscript; available in PMC: 2017 Jul 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1273–1280. doi: 10.1016/j.ijrobp.2016.02.058

Figure 4.

Figure 4

Histograms characterizing the difference between dose and dose-function metrics. Difference are shown for MLD for stage III patients (A), V20 for stage III patients (B), MLD for stage I patients (C), and V10 for stage I patients (D).